Latent viral infections in young patients with inflammatory diseases treated with biological agents: Prevalence of JC virus genotype 2

Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab

(2012) Simone Giannecchini et al.   JOURNAL OF NEUROVIROLOGY

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension

(2011) Jeffrey Hyams et al.   CURRENT MEDICAL RESEARCH AND OPINION

Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab

(2011) Anna Bellizzi et al.   JOURNAL OF NEUROVIROLOGY

Assessment of JC virus DNA in blood and urine from natalizumab-treated patients

(2010) Richard A. Rudick et al.   ANNALS OF NEUROLOGY

A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab

(2010) Deepak Kumar et al.   ARTHRITIS AND RHEUMATISM

JCV detection in multiple sclerosis patients treated with natalizumab

(2010) Saud A. Sadiq et al.   JOURNAL OF NEUROLOGY

Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy

(2010) Roisin M Lonergan et al.   JOURNAL OF NEUROVIROLOGY

Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab

(2009) Yiping Chen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Seroepidemiology of Human Polyomaviruses

(2009) Jaime M. Kean et al.   PLoS Pathogens

JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?

(2008) J Verbeeck et al.   GUT

Cytomegalovirus colitis in a patient with Behcet’s disease receiving tumor necrosis factor alpha inhibitory treatment

(2008) Ismail Sari et al.   WORLD JOURNAL OF GASTROENTEROLOGY